SS INNOVATIONS INTERNATIONAL, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
SS INNOVATIONS INTERNATIONAL, INC. (SSII) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $14.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-13
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $15.79M, a 2.36% increase year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $15.43M.
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$160.91K, a 369.73% decline year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $59.66K.
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $3.96M.
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$738.53K, a 110.58% decline from fiscal 2023.
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $6.98M, a 4799.03% increase from fiscal 2022.
- SS INNOVATIONS INTERNATIONAL, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $142.50K, a 41.85% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.88M 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | $15.79M 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | $3.96M 10-K · filed 2026-03-10 | |||||||
| 2025-09-30 | $5.83M 10-Q · filed 2025-10-28 | |||||||
| 2025-06-30 | $10.96M 10-Q · filed 2026-08-13 | |||||||
| 2025-03-31 | $15.43M 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | -$738.53K 10-K · filed 2026-03-10 | |||||||
| 2024-09-30 | -$762.66K 10-Q · filed 2025-10-28 | -$1.11M 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | -$641.01K 10-Q · filed 2025-08-06 | $26.32K 10-Q · filed 2024-09-06 | ||||||
| 2024-03-31 | -$160.91K 10-Q · filed 2025-05-14 | -$129.88K 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | $6.98M 10-K · filed 2025-04-15 | $862.85K 10-K · filed 2024-03-22 | ||||||
| 2023-09-30 | $11.35M 10-Q/A · filed 2025-04-01 | $5.24M 10-Q · filed 2023-11-13 | ||||||
| 2023-06-30 | $277.64K 10-Q/A · filed 2025-03-10 | -$928.30K 10-Q · filed 2023-08-07 | ||||||
| 2023-03-31 | $59.66K 10-Q/A · filed 2025-02-19 | -$902.82K 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | $142.50K 10-K/A · filed 2024-12-20 | $1.00M 10-K · filed 2024-03-22 | ||||||
| 2022-09-30 | $46.44K 10-Q/A · filed 2025-01-14 | $108.37K 10-Q · filed 2022-11-30 | ||||||
| 2022-06-30 | $11.22K 10-Q/A · filed 2025-01-14 | -$144.69K 10-Q · filed 2022-11-30 | ||||||
| 2022-03-31 | -$58.91K 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | $245.06K 10-K · filed 2022-11-04 | |||||||
| 2021-09-30 | $44.49K 10-Q · filed 2022-11-30 | |||||||
| 2021-06-30 | $146.86K 10-Q · filed 2022-11-30 | |||||||
| 2021-03-31 | $156.10K 10-Q · filed 2022-11-30 | |||||||
| 2020-12-31 | $132.24K 10-K · filed 2022-11-04 | |||||||
| 2020-09-30 | -$27.79K 10-Q · filed 2022-11-04 | |||||||
| 2020-06-30 | -$23.06K 10-Q · filed 2022-11-04 | |||||||
| 2020-03-31 | -$18.35K 10-Q · filed 2022-11-04 | |||||||
| 2019-12-31 | -$7.24K 10-K · filed 2022-09-06 | |||||||
| 2019-06-30 | $3.38K 10-Q · filed 2022-07-18 | |||||||
| 2019-03-31 | $25.81K 10-Q · filed 2022-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |